Santen Pharmaceutical Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Santen Pharmaceutical Co., Ltd. owes ¥0.28 for every ¥1 it owns. Net profit rose 3% in the year to Mar 2026.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
14.7Investors pay ¥14.7 for every ¥1 of Santen Pharmaceutical Co., Ltd.'s yearly profit, lower than 57% of Healthcare companies in Japan.
P/B ratio
1.89The share price is 1.89 times Santen Pharmaceutical Co., Ltd.'s book value per share, higher than 60% of Healthcare companies in Japan.
Market cap
¥566.4 BThe total market value of all of Santen Pharmaceutical Co., Ltd.'s shares at today's price (share price × number of shares), larger than 91% of Healthcare companies in Japan. PosiCap size class: Meso Cap.
Net worth (book value)
¥300.3 BWhat Santen Pharmaceutical Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥934.57Net worth divided by the number of shares. The share price of ¥1,763 is 1.9 times this, which is the P/B above.
Return on equity (ROE)
13.4%Santen Pharmaceutical Co., Ltd. earned 13.4% on its shareholders' money over the last year, higher than 78% of Healthcare companies in Japan.
Owes vs Owns
0.28×Santen Pharmaceutical Co., Ltd. owes ¥0.28 for every ¥1 it owns (low).
Dividend yield
2.40%Santen Pharmaceutical Co., Ltd. pays 2.40% of its share price as dividends a year, lower than 60% of dividend-paying Healthcare companies in Japan.
Revenue growth
-3%Revenue fell 3% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Profit growth
+3%Net profit rose 3% in the year to Mar 2026.
Profit margin
12.8%Santen Pharmaceutical Co., Ltd. keeps ¥13 of every ¥100 of revenue as net profit.
Interest cover
24.0×Santen Pharmaceutical Co., Ltd.'s operating profit covered its interest costs 24.0 times in the year to Mar 2026.
Questions
What is Santen Pharmaceutical Co., Ltd.'s P/E ratio?
Investors pay ¥14.7 for every ¥1 of Santen Pharmaceutical Co., Ltd.'s yearly profit, lower than 57% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Santen Pharmaceutical Co., Ltd.: ¥566.4 B ÷ ¥300.3 B (30 Jun 2026) = 1.9.
What is Santen Pharmaceutical Co., Ltd.'s return on equity?
Santen Pharmaceutical Co., Ltd. earned 13.4% on its shareholders' money over the last year, higher than 78% of Healthcare companies in Japan.
How much does Santen Pharmaceutical Co., Ltd. owe compared with what it owns?
Santen Pharmaceutical Co., Ltd. owes ¥0.28 for every ¥1 it owns (low).
Does Santen Pharmaceutical Co., Ltd. pay a dividend?
Yes. Santen Pharmaceutical Co., Ltd. pays 2.40% of its share price as dividends a year, lower than 60% of dividend-paying Healthcare companies in Japan.
Is Santen Pharmaceutical Co., Ltd.'s revenue growing?
Revenue fell 3% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.